OBJECTIVE: To determine the types of chronic disease management (CDM) programs offered for patients with diabetes in Alberta's primary care networks (PCNs). DESIGN: A survey was administered to PCNs to determine the types of CDM programs offered for patients with diabetes; CDM programs were organized into categories by their resource intensity and effectiveness. Results of the survey were reported using frequencies and percentages. SETTING: Alberta has recently created PCNs-groups of family physicians who receive additional funds to enable them to support activities that fall outside the typical physician-based fee-for-service model, but which address specified objectives including CDM. It is currently unknown what additional programs are being provided through the PCN supplemental funding. PARTICIPANTS: A survey was administered to the individual responsible for CDM in each PCN. This included executive directors, chronic disease managers, and CDM nurses. MAIN OUTCOME MEASURES: We determined the CDM strategies used in each PCN to care for patients with diabetes, whether they were available to all patients, and whether the services were provided exclusively by the PCN or in conjunction with other agencies. RESULTS: There was considerable variation across PCNs with respect to the CDM programs offered for people with diabetes. Nearly all PCNs used multidisciplinary teams (which could include nurses, dietitians, and pharmacists) and patient education. Fewer than half of the PCNs permitted personnel other than the primary physician to write or alter prescriptions for medications. CONCLUSION: Alberta's PCNs have successfully established many different types of CDM programs. Multidisciplinary care teams, which are among the most effective CDM strategies, are currently being used by most of Alberta's PCNs.
OBJECTIVE: To determine the types of chronic disease management (CDM) programs offered for patients with diabetes in Alberta's primary care networks (PCNs). DESIGN: A survey was administered to PCNs to determine the types of CDM programs offered for patients with diabetes; CDM programs were organized into categories by their resource intensity and effectiveness. Results of the survey were reported using frequencies and percentages. SETTING: Alberta has recently created PCNs-groups of family physicians who receive additional funds to enable them to support activities that fall outside the typical physician-based fee-for-service model, but which address specified objectives including CDM. It is currently unknown what additional programs are being provided through the PCN supplemental funding. PARTICIPANTS: A survey was administered to the individual responsible for CDM in each PCN. This included executive directors, chronic disease managers, and CDM nurses. MAIN OUTCOME MEASURES: We determined the CDM strategies used in each PCN to care for patients with diabetes, whether they were available to all patients, and whether the services were provided exclusively by the PCN or in conjunction with other agencies. RESULTS: There was considerable variation across PCNs with respect to the CDM programs offered for people with diabetes. Nearly all PCNs used multidisciplinary teams (which could include nurses, dietitians, and pharmacists) and patient education. Fewer than half of the PCNs permitted personnel other than the primary physician to write or alter prescriptions for medications. CONCLUSION: Alberta's PCNs have successfully established many different types of CDM programs. Multidisciplinary care teams, which are among the most effective CDM strategies, are currently being used by most of Alberta's PCNs.
Authors: B M Brenner; M E Cooper; D de Zeeuw; W F Keane; W E Mitch; H H Parving; G Remuzzi; S M Snapinn; Z Zhang; S Shahinfar Journal: N Engl J Med Date: 2001-09-20 Impact factor: 91.245
Authors: Helen M Colhoun; D John Betteridge; Paul N Durrington; Graham A Hitman; H Andrew W Neil; Shona J Livingstone; Margaret J Thomason; Michael I Mackness; Valentine Charlton-Menys; John H Fuller Journal: Lancet Date: 2004 Aug 21-27 Impact factor: 79.321
Authors: Peter Gaede; Pernille Vedel; Nicolai Larsen; Gunnar V H Jensen; Hans-Henrik Parving; Oluf Pedersen Journal: N Engl J Med Date: 2003-01-30 Impact factor: 91.245
Authors: Bruce M Psaty; Thomas Lumley; Curt D Furberg; Gina Schellenbaum; Marco Pahor; Michael H Alderman; Noel S Weiss Journal: JAMA Date: 2003-05-21 Impact factor: 56.272
Authors: Braden J Manns; Marcello Tonelli; Jianguo Zhang; David J T Campbell; Peter Sargious; Bharati Ayyalasomayajula; Fiona Clement; Jeffrey A Johnson; Andreas Laupacis; Richard Lewanczuk; Kerry McBrien; Brenda R Hemmelgarn Journal: CMAJ Date: 2011-12-05 Impact factor: 8.262
Authors: Robert G Weaver; Braden J Manns; Marcello Tonelli; Claudia Sanmartin; David J T Campbell; Paul E Ronksley; Richard Lewanczuk; Ted C Braun; Deirdre Hennessy; Brenda R Hemmelgarn Journal: CMAJ Open Date: 2014-03-07
Authors: David J T Campbell; Harleen Ghuttora; Ana Mladenovic; Jordan Smith; Ryan Leigh; Laura Desveaux; Noah Ivers; Braden Manns; Marcello Tonelli; Christopher Naugler; Brenda Hemmelgarn; Kerry A McBrien Journal: Clin Diabetes Date: 2022
Authors: Braden Manns; Ted Braun; Alun Edwards; Jeremy Grimshaw; Brenda Hemmelgarn; Don Husereau; Noah Ivers; Jeff Johnson; Steve Long; Kerry McBrien; Christopher Naugler; Peter Sargious; Sharon Straus; Marcello Tonelli; Andrea C Tricco; Catherine Yu Journal: CMAJ Open Date: 2013-11-20
Authors: Viviane F A Van Casteren; Nathalie H E Bossuyt; Sarah J S Moreels; Geert Goderis; Katrien Vanthomme; Johan Wens; Etienne W De Clercq Journal: Arch Public Health Date: 2015-07-13
Authors: Julia Lukewich; Renée Corbin; Elizabeth G VanDenKerkhof; Dana S Edge; Tyler Williamson; Joan E Tranmer Journal: J Eval Clin Pract Date: 2014-05-20 Impact factor: 2.431
Authors: David J T Campbell; Paul E Ronksley; Brenda R Hemmelgarn; Jianguo Zhang; Cheryl Barnabe; Marcello Tonelli; Braden Manns Journal: Open Med Date: 2012-12-11